AN2 Therapeutics, Inc. ($ANTX)
Readnour Robin Shane โ Director
Shares
4,725
Price
$6.02
Total Value
$28,436.47
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Readnour Robin Shane |
|---|---|
| Title | Director |
| Transaction Date | Sep 8, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Indirect |
| Nature of Ownership | See footnotes |
| Filing Date | Sep 8, 2026 |
| Shares Sold | 4,725 |
| Price per Share | $6.02 |
| Total Value | $28,436.47 |
| Shares Owned After | 557,990 |
| Derivative | No |
| Accession Number | 0001193125-26-385511 |
| Document | View SEC Filing |